◂ Announcements

Jul 25, 2019EXPANSIONVisp, Switzerland

Lonza expands ADC facility in Visp, Switzerland with two new suites

Lonza is adding two new conjugation suites to its antibody-drug conjugate (ADC) facility in Visp, Switzerland, with new capacity expected online by Q3 2021.

Starts operating

Q3 2021

Status

Under construction

Capacity

two additional suites

Productsantibody-drug conjugates (ADCs)

CompaniesLonza Group AG

Sectors#Medical Devices

“We are building two additional floors onto the existing building, adding two suites to the existing five.”bioprocessintl.com

1 source
bioprocessintl.comLonza building out capacity to prep for ADC boomDan StantonJul 25, 2019

Summarized from public sources; check the original articles before acting on it.

More from Lonza Group AG

profile ▸

Jun 30, 2021EXPANSIONNansha, China, China$21.0Mops Q1 2022
Lonza to invest €18 million in API centre expansion in Nansha, China
Lonza Group AG viewer.joomag.com
Feb 8, 2021ACQUISITIONBasel, Switzerland, Switzerland$4.60B
Bain Capital and Cinven to acquire Lonza Specialty Ingredients for CHF 4.2B
Bain Capital Private Equity acquirer Lonza Group AG target cinven.com
May 5, 2020PARTNERSHIP
Moderna and Lonza collaborate to manufacture COVID-19 vaccine
Lonza Group AG partner Moderna partner socma.org
Jun 19, 2019CONTRACTPrince Edward Island, Canada
Auxly subsidiary Dosecann signs agreement with Lonza for capsule filling equipment
Auxly Cannabis Group Dosecann globenewswire.com
Feb 28, 2019ACQUISITIONAlpharetta, Georgia, United States$630.0M
Platinum Equity completes acquisition of Lonza's water care business for $630M
Platinum Equity acquirer Lonza Group AG partner platinumequity.com globenewswire.com labusinessjournal.com
Feb 17, 2019CONTRACTNansha, China; Edinburgh, Scotland; Ploermel, France, China
Emerald Health signs Lonza to manufacture cannabinoid API
Lonza Group AG supplier Emerald Health Pharmaceuticals customer doi.org

Loading…

Lonza expands ADC facility in Visp, Switzerland with two new suites · Endata